abstract |
the present invention relates to a pharmaceutical composition administered orally, in the form of liquid capsules, comprising a fixed dose combination of cinitapride tartrate and simethicone together with at least one surfactant and, optionally, one or more pharmaceutically acceptable excipients , and the method for obtaining said composition. |